These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Wang G; Xiao L; Zhang M; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC Hum Pathol; 2018 Sep; 79():57-65. PubMed ID: 29763719 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics. Shen P; Jing Y; Zhang R; Cai MC; Ma P; Chen H; Zhuang G Oncogene; 2018 May; 37(22):3039-3044. PubMed ID: 29535424 [TBL] [Abstract][Full Text] [Related]
6. Sex discrepancy characterization revealed by somatic DNA alterations in muscle-invasive bladder carcinoma. Wu TZ; Lei CY; Li JM; Guo YF Chin Med J (Engl); 2019 Oct; 132(20):2492-2494. PubMed ID: 31651512 [No Abstract] [Full Text] [Related]
7. Analysis of genetic alterations in normal bladder urothelium. Leonardo C; Gallucci M; Cianciulli AM Urology; 2004 Aug; 64(2):405; author reply 405-6. PubMed ID: 15302516 [No Abstract] [Full Text] [Related]
8. Bilateral retinoblastoma due to a germline mutation of RB1 in a child with down syndrome. Le Grignou M; Bleriot A; Nizon M; Pacquement H; Houdayer C; Thebaud E; Le Meur G; Isidor B Ophthalmic Genet; 2019 Feb; 40(1):86. PubMed ID: 30822236 [No Abstract] [Full Text] [Related]
9. CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of Rubio C; Martínez-Fernández M; Segovia C; Lodewijk I; Suarez-Cabrera C; Segrelles C; López-Calderón F; Munera-Maravilla E; Santos M; Bernardini A; García-Escudero R; Lorz C; Gómez-Rodriguez MJ; de Velasco G; Otero I; Villacampa F; Guerrero-Ramos F; Ruiz S; de la Rosa F; Domínguez-Rodríguez S; Real FX; Malats N; Castellano D; Dueñas M; Paramio JM Clin Cancer Res; 2019 Jan; 25(1):390-402. PubMed ID: 30242024 [TBL] [Abstract][Full Text] [Related]
10. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells. Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036 [TBL] [Abstract][Full Text] [Related]
12. [Principles of tumor invasion and metastasis]. Otto T; Goepel M; Recker F; Rübben H Urologe A; 1995 May; 34(3):208-11. PubMed ID: 7610514 [TBL] [Abstract][Full Text] [Related]
13. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family. Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630 [No Abstract] [Full Text] [Related]
14. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Vasaikar SV; Straub P; Wang J; Zhang B Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207 [TBL] [Abstract][Full Text] [Related]
15. Unilateral retinoblastoma in a patient with Hermansky-Pudlak syndrome. Burges M; King B; McGee R; Brennan R; Wilson M Ophthalmic Genet; 2019 Feb; 40(1):83-85. PubMed ID: 30712445 [No Abstract] [Full Text] [Related]
16. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications. Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047 [TBL] [Abstract][Full Text] [Related]
17. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases. Lima L; Neves M; Oliveira MI; Dieguez L; Freitas R; Azevedo R; Gaiteiro C; Soares J; Ferreira D; Peixoto A; Fernandes E; Montezuma D; Tavares A; Ribeiro R; Castro A; Oliveira M; Fraga A; Reis CA; Santos LL; Ferreira JA Urol Oncol; 2017 Dec; 35(12):675.e1-675.e8. PubMed ID: 28911924 [TBL] [Abstract][Full Text] [Related]
18. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study. Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636 [TBL] [Abstract][Full Text] [Related]
19. Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene. Sakano S; Berggren P; Kumar R; Steineck G; Adolfsson J; Onelöv E; Hemminki K; Larsson P Int J Cancer; 2003 Mar; 104(1):98-103. PubMed ID: 12532425 [TBL] [Abstract][Full Text] [Related]
20. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy. Chaussade A; Millot G; Wells C; Brisse H; Laé M; Savignoni A; Desjardins L; Dendale R; Doz F; Aerts I; Jimenez I; Cassoux N; Stoppa Lyonnet D; Gauthier Villars M; Houdayer C Eur J Med Genet; 2019 Mar; 62(3):217-223. PubMed ID: 30031154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]